« Maple Leaf Foods Misleads Public! | Main | Vioxx Juries »
September 14, 2005
Inhaled Insulin
How much will the FDA change in a post-Vioxx world?
The gist of the article is that the FDA's review of Exubera, Pfizer's inhalable insulin, will be a test case to see how the post-Vioxx administration will handle drugs that come with potential hazards. The interesting bit to me, as a diabetic who also enjoys breathing, was this:
|
Related Products: |
Read more from this blogger: |
Posted on September 14, 2005 04:45 PM by Vioxx68.
Filed in Personal Injury Resources under vioxx.
Permalink 
| Comments (0)
